UPCC 43419: Prospective Study of Immune Biomarkers in Patients with Multiple Myeloma
Enrolling By Invitation
99 years or below
All
30 participants needed
1 Location
Brief description of study
The objective of this exploratory observational cohort study is to obtain blood samples - and in some cases, bone marrow aspirate samples - from patients with multiple myeloma for study in the laboratory.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: myeloma
-
Age: 99 years or below
-
Gender: All
Updated on
04 Aug 2024.
Study ID: 834039
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245
